| Product Code: ETC13312515 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Drug Repurposing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Drug Repurposing Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Drug Repurposing Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Drug Repurposing Market - Industry Life Cycle |
3.4 Europe Drug Repurposing Market - Porter's Five Forces |
3.5 Europe Drug Repurposing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Drug Repurposing Market Revenues & Volume Share, By Approach, 2021 & 2031F |
3.7 Europe Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
3.8 Europe Drug Repurposing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Drug Repurposing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Europe Drug Repurposing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Drug Repurposing Market Trends |
6 Europe Drug Repurposing Market, 2021 - 2031 |
6.1 Europe Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Drug Repurposing Market, Revenues & Volume, By On-Target Repurposing, 2021 - 2031 |
6.1.3 Europe Drug Repurposing Market, Revenues & Volume, By Off-Target Repurposing, 2021 - 2031 |
6.1.4 Europe Drug Repurposing Market, Revenues & Volume, By Combination Drug Repurposing, 2021 - 2031 |
6.1.5 Europe Drug Repurposing Market, Revenues & Volume, By Pathway-Based Repurposing, 2020 - 2028 |
6.2 Europe Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Drug Repurposing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Europe Drug Repurposing Market, Revenues & Volume, By Neurodegenerative Diseases, 2021 - 2031 |
6.2.4 Europe Drug Repurposing Market, Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031 |
6.2.5 Europe Drug Repurposing Market, Revenues & Volume, By Infectious Diseases, 2021 - 2031 |
6.3 Europe Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Drug Repurposing Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.3.3 Europe Drug Repurposing Market, Revenues & Volume, By Biotechnology Firms, 2021 - 2031 |
6.3.4 Europe Drug Repurposing Market, Revenues & Volume, By Academic Research Institutes, 2021 - 2031 |
6.3.5 Europe Drug Repurposing Market, Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031 |
6.4 Europe Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Drug Repurposing Market, Revenues & Volume, By Computational Drug Repurposing, 2021 - 2031 |
6.4.3 Europe Drug Repurposing Market, Revenues & Volume, By High-Throughput Screening, 2021 - 2031 |
6.4.4 Europe Drug Repurposing Market, Revenues & Volume, By Biomarker-Based Repurposing, 2020 - 2028 |
6.4.5 Europe Drug Repurposing Market, Revenues & Volume, By AI & Machine Learning in Drug Repurposing, 2020 - 2028 |
7 Europe Drug Repurposing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.1 United Kingdom (UK) Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.2 Germany Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.3 France Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.4 Poland Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.5 Spain Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.2.6 Rest of Europe Drug Repurposing Market, Revenues & Volume, By Approach, 2021 - 2031 |
7.3 Europe Drug Repurposing Market Revenues & Volume Share, By Disease Area, 2021 & 2031F |
7.3.1 United Kingdom (UK) Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.2 Germany Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.3 France Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.4 Poland Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.5 Spain Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.3.6 Rest of Europe Drug Repurposing Market, Revenues & Volume, By Disease Area, 2021 - 2031 |
7.4 Europe Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Drug Repurposing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United Kingdom (UK) Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Germany Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 France Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.4 Poland Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.5 Spain Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.6 Rest of Europe Drug Repurposing Market, Revenues & Volume, By Technology, 2021 - 2031 |
8 Europe Drug Repurposing Market Key Performance Indicators |
9 Europe Drug Repurposing Market - Export/Import By Countries Assessment |
10 Europe Drug Repurposing Market - Opportunity Assessment |
10.1 Europe Drug Repurposing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Drug Repurposing Market Opportunity Assessment, By Approach, 2021 & 2031F |
10.3 Europe Drug Repurposing Market Opportunity Assessment, By Disease Area, 2021 & 2031F |
10.4 Europe Drug Repurposing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Drug Repurposing Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Europe Drug Repurposing Market - Competitive Landscape |
11.1 Europe Drug Repurposing Market Revenue Share, By Companies, 2022 |
11.2 Europe Drug Repurposing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here